Home/Immunovia/Jeff Borcherding

JB

Jeff Borcherding

Chief Executive Officer

Therapeutic Areas

Oncology Pancreatic Cancer

Immunovia Pipeline

Drug	Indication	Phase
PancreaSure	Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in High-Risk Individuals	Commercial Preparation

Leadership Team at Immunovia

Norma Palma, PhD

VP, Clinical & Medical Affairs

Lisa Ford, PhD, HCLD

Clinical Lab Director

Tom King, MD, PhD

Medical Director

View full Immunovia profile